The spectrum of clinical biomarkers in severe malaria and new avenues for exploration

References

• WHO. World Malaria Report. Geneva: World Health Organization; 2021. Available from: https://www.who.int/publications/i/item/9789240015791
   Google Scholar
• Cowman AF, Healer J, Marapana D, et al. Malaria: biology and disease. Cell [Internet]. 2016;167(3):610–624. DOI:http://dx.doi.org/10.1016/j.cell.2016.07.055.
   PubMed Web of Science ®Google Scholar
• Trampuz A, Jereb M, Muzlovic I, et al. Clinical review: severe malaria. Crit Care [Internet]. 2003;7(4):315–323. https://doi.org/10.1186/cc2183.
   PubMed Web of Science ®Google Scholar
• Kotepui M, Kotepui KU, Milanez GD, et al. Severity and mortality of severe Plasmodium ovale infection: a systematic review and meta-analysis. PLoS One [Internet]. 2020;15(6):e0235014. http://dx.doi.org/10.1371/journal.pone.0235014.
   PubMed Web of Science ®Google Scholar
• Kotepui M, Kotepui KU, Milanez GD, et al. Prevalence of severe Plasmodium knowlesi infection and risk factors related to severe complications compared with non-severe P. knowlesi and severe P. falciparum malaria: a systematic review and meta-analysis. Infect Dis Pov [Internet]. 2020;9(1):106. https://doi.org/10.1186/s40249-020-00727-x.
   PubMed Web of Science ®Google Scholar
• Kotepui M, Kotepui KU, Milanez GD, et al. Global prevalence and mortality of severe Plasmodium malariae infection: a systematic review and meta-analysis. Malar J [Internet]. 2020;19(1):274. https://doi.org/10.1186/s12936-020-03344-z.
   PubMed Web of Science ®Google Scholar
• Makumbe B, Tshuma C, Shambira G, et al. Evaluation of severe malaria case management in Mazowe district, Zimbabwe, 2014. Pan Afr Med J [Internet]. 2017;27:33. DOI:10.11604/pamj.2017.27.33.11081.
   PubMed Web of Science ®Google Scholar
• Elnour FA, Alagib MEA, Bansal D, et al. Severe malaria management: Current situation, challenges and lessons learned from Gezira State, Sudan. Malar J [Internet]. 2019;18(1):170. https://doi.org/10.1186/s12936-019-2805-z.
   PubMedGoogle Scholar
• WHO. World malaria report 2019 [Internet]. Geneva; 2019. Available from: www.who.int
   Google Scholar
• Taylor C, Namaste SML, Lowell J, et al. Estimating the fraction of severe malaria among malaria-positive children: analysis of household surveys in 19 malaria-endemic countries in Africa. Am J Trop Med Hyg [InternetAhead of print]. 2021;104(4):1375–1382. https://doi.org/10.4269/ajtmh.20-1351.
   PubMed Web of Science ®Google Scholar
• Kojom Foko LP, Arya A, Sharma A, et al. Epidemiology and clinical outcomes of severe Plasmodium vivax malaria in India. J Infect. 2021;82(6):231–246. https://doi.org/10.1016/j.jinf.2021.03.028.
   PubMed Web of Science ®Google Scholar
• Greenhalgh S, Chandwani V. Advocating an attack against severe malaria: a cost-effectiveness analysis. BMC Public Health. 2020;20(1):17.
   PubMed Web of Science ®Google Scholar
• WHO. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94:S1–S90.
   PubMed Web of Science ®Google Scholar
• WHO. Guidelines for treatment of malaria. Geneva: The World health Organization; 2006.
   Google Scholar
• WHO. Guidelines for the treatment of malaria [Internet]. Second Edition. Geneva; 2010. Available from: https://www.ncbi.nlm.nih.gov/books/NBK254223/pdf/Bookshelf_NBK254223.pdf
   Google Scholar
• WHO. Management of severe malaria. 3rd ed. Geneva: World Health Organization; 2012.
   Google Scholar
• WHO. Severe malaria. Trop Med Int Health. 2014;19:7–131.
   PubMed Web of Science ®Google Scholar
• WHO. Guidelines for the treatment of malaria - Third edition [Internet]. Geneva; 2015. Available from: https://www.ncbi.nlm.nih.gov/books/NBK294440/pdf/Bookshelf_NBK294440.pdf
   Google Scholar
• Sypniewska P, Duda JF, Locatelli I, et al. Clinical and laboratory predictors of death in African children with features of severe malaria: a systematic review and meta-analysis. BMC Med. 2017;15:147. Available from:
   PubMed Web of Science ®Google Scholar
• Jallow M, Casals-Pascual C, Ackerman H, et al. Clinical features of severe malaria associated with death: a 13-year observational study in the Gambia. PLoS One. 2012;7(9):e45645. DOI:10.1371/journal.pone.0045645.
   PubMed Web of Science ®Google Scholar
• Schwartz E, Sadetzki S, Murad H, et al. Age as a risk factor for severe Plasmodium falciparum malaria in nonimmune patients. Clin Infec Dis. 2001;33(10):1774–1777. https://doi.org/10.1086/322522.
   PubMed Web of Science ®Google Scholar
• Barcus MJ, Basri H, Picarima H, et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in Northeastern Indonesian Papua. Am J Trop Med Hyg. 2007;77:984–991.
   PubMed Web of Science ®Google Scholar
• Fried M, Duffy PE. Parasite burden and severity of malaria in Tanzanian children. N Engl J Med. 2014;370:1799–1808.
   PubMed Web of Science ®Google Scholar
• Mpimbaza A, Ndeezi G, Katahoire A, et al. Demographic, socioeconomic, and geographic factors leading to severe malaria and delayed care seeking in Ugandan children: a case–control study. Am J Trop Med Hyg. 2017;97(5):1513–1523. https://doi.org/10.4269/ajtmh.17-0056.
   PubMed Web of Science ®Google Scholar
• Mutsigiri-Murewanhema F, Mafaune PT, Shambira G, et al. Factors associated with severe malaria among children below ten years in Mutasa and Nyanga districts, Zimbabwe, 2014-2015. Pan Afr Med J. 2017;27:23.
   PubMed Web of Science ®Google Scholar
• Khuu D, Eberhard ML, Bristow BN, et al. Risk factors for severe malaria among hospitalized patients in the United States, 2000–2014. Infect Dis Health. 2018;23(2):93–106. https://doi.org/10.1016/j.idh.2018.01.002.
   Web of Science ®Google Scholar
• Kwan JL, Seitz AE, Fried M, et al. Seroepidemiology of helminths and the association with severe malaria among infants and young children in Tanzania. PLoS Negl Trop Dis. 2018;12(3):e0006345. https://doi.org/10.1371/journal.pntd.0006345.
   PubMed Web of Science ®Google Scholar
• Xia J, Wu D, Wu K, et al. Epidemiology of Plasmodium falciparum malaria and risk factors for severe disease in Hubei Province, China. Am J Trop Med Hyg. 2020;103(4):1534–1539. https://doi.org/10.4269/ajtmh.20-0299.
   PubMed Web of Science ®Google Scholar
• Phillips A, Bassett P, Zeki S, et al. Risk factors for severe disease in adults with falciparum malaria. Clin Infec Dis. 2009;48(7):871–878. https://doi.org/10.1086/597258.
   PubMed Web of Science ®Google Scholar
• Lucchi NW, Jain V, Wilson NO, et al. Potential serological biomarkers of cerebral malaria. Dis Markers. 2011;31:327–335.
   PubMed Web of Science ®Google Scholar
• Clark GM. Prognostic factors versus predictive factors : examples from a clinical trial of erlotinib 5. Mol Oncol. 2008;1(4):406–412.
   PubMed Web of Science ®Google Scholar
• Italiano A. Prognostic or predictive? It’s time to get back to definitions! J Clin Oncol. 2011;29(35):4718.
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Losina E, Guermazi A, et al. A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials. Curr Drug Targets. 2010;11(5):536–545. https://doi.org/10.2174/138945010791011947.
   PubMed Web of Science ®Google Scholar
• Lesko L, Atkinson A Jr. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: Criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001;41(1):347–366.
   PubMedGoogle Scholar
• No author listed. Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”. Neurobiol Aging. 1998;19(2):109–116. DOI:10.1016/S0197-4580(98)00022-0.
   PubMed Web of Science ®Google Scholar
• Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96(5):644–647.
   PubMed Web of Science ®Google Scholar
• Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315–1316.
   PubMed Web of Science ®Google Scholar
• Gupta P, Guddattu V, Saravu K. Characterization of platelet count and platelet indices and their potential role to predict severity in malaria. Pathog Glob Health. 2019;113(2):86–93.
   PubMed Web of Science ®Google Scholar
• Mohapatra MK, Thomas GA, Kumar Bariha P, et al. Serum procalcitonin: as a Triage tool for severe Plasmodium falciparum malaria. J Trop Dis. 2013;1:4.
   Google Scholar
• Bhardwaj N, Ahmed M, Sharma S, et al. C-Reactive protein as a prognostic marker of Plasmodium falciparum malaria severity. J Vector Borne Dis. 2019;56:122–126.
   PubMed Web of Science ®Google Scholar
• Gérardin P, Rogier C, Ka AS, et al. Prognostic value of thrombocytopenia in African children with falciparum malaria. Am J Trop Med Hyg. 2002;66:686–691.
   PubMed Web of Science ®Google Scholar
• Righi E, Merelli M, Arzese A, et al. Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria. Acta Parasitol. 2016;61(2):412–418. DOI:10.1515/ap-2016-0055.
   PubMed Web of Science ®Google Scholar
• Salih MM, Eltahir HG, Abdallah TM, et al. Haematological parameters, haemozoin-containing leukocytes in Sudanese children with severe Plasmodium falciparum malaria. J Infect Dev Ctries. 2018;12:273–278.
   PubMed Web of Science ®Google Scholar
• Oluboyo A, Chukwu S, Oluboyo B, et al. Evaluation of angiopoietins 1 and 2 in malaria-infested children. J Environ Public Health. 2020;2020:2169763.
   PubMed Web of Science ®Google Scholar
• Erdman LK, Dhabangi A, Musoke C, et al. Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One. 2011;6(2):e17440. DOI:10.1371/journal.pone.0017440.
   PubMed Web of Science ®Google Scholar
• Conroy AL, Phiri H, Hawkes M, et al. Endothelium-Based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study. PLoS One. 2010;5(12):e15291. DOI:10.1371/journal.pone.0015291.
   PubMed Web of Science ®Google Scholar
• Conroy AL, Glover SJ, Hawkes M, et al. Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study. Cri Care Med. 2012;40(3):952–959. DOI:10.1097/CCM.0b013e3182373157.
   PubMed Web of Science ®Google Scholar
• Stauga S, Hahn A, Brattig NW, et al. Clinical relevance of different biomarkers in imported Plasmodium falciparum malaria in adults: a case control study. Malar J. 2013;12(1):246. DOI:10.1186/1475-2875-12-246.
   PubMedGoogle Scholar
• Park GS, Ireland KF, Opoka RO, et al. Evidence of endothelial activation in asymptomatic Plasmodium falciparum parasitemia and effect of blood group on levels of von Willebrand factor in Malaria. J Pediatric Infect Dis Soc. 2012;1(1):16–25. DOI:10.1093/jpids/pis010.
   PubMedGoogle Scholar
• Andrade BB, Reis-Filho A, Souza-Neto SM, et al. Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. PLoS Med. 2010;4:e650.
   Google Scholar
• Jain V, Lucchi NW, Wilson NO, et al. Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India. Malar J [ Available from]. 2011;10(1):383. DOI:10.1186/1475-2875-10-383.
   PubMedGoogle Scholar
• Raza A, Ghanchi NK, Zubairi ABS, et al. Tumor necrosis factor -α, interleukin-10, intercellular and vascular adhesion molecules are possible biomarkers of disease severity in complicated Plasmodium vivax isolates from Pakistan. PLoS One. 2013;8(12):e81363. DOI:10.1371/journal.pone.0081363.
   PubMed Web of Science ®Google Scholar
• Willmann M, Ahmed A, Siner A, et al. Laboratory markers of disease severity in Plasmodium knowlesi infection: a case control study. Malar J. 2012;11(1):363. DOI:10.1186/1475-2875-11-363.
   PubMedGoogle Scholar
• Barber BE, Grigg MJ, Piera KA, et al. Intravascular haemolysis in severe Plasmodium knowlesi malaria: association with endothelial activation, microvascular dysfunction, and acute kidney injury. Emerg Microbes Infect. 2018;7(1):106. DOI:http://dx.doi.org/10.1038/s41426-018-0105-2.
   PubMed Web of Science ®Google Scholar
• Hawadak J, Dongang Nana RR, Singh V. Global trend of Plasmodium malariae and Plasmodium ovale spp. malaria infections in the last two decades (2000–2020): a systematic review and meta-analysis. Parasite Vectors. 2021;14(1):297.
   PubMed Web of Science ®Google Scholar
• Conroy AL, Hawkes M, McDonald CR, et al. Host biomarkers are associated with response to therapy and long-term mortality in pediatric severe malaria. Open Forum Infect Dis. 2016;3(3):ofw134. DOI:10.1093/ofid/ofw134.
   PubMed Web of Science ®Google Scholar
• Yeo TW, Lampah DA, Kenangalem E, et al. Increased carboxyhemoglobin in adult falciparum malaria is associated with disease severity and mortality. J Infect Dis. 2013;208(5):813–817. DOI:10.1093/infdis/jit253.
   PubMed Web of Science ®Google Scholar
• Huang H, Ideh RC, Gitau E, et al. Discovery and validation of biomarkers to guide clinical management of pneumonia in African children. Clin Infect Dis. 2014;58(12):1707–1715. DOI:10.1093/cid/ciu202.
   PubMed Web of Science ®Google Scholar
• Mahanta A, Kar SK, Kakati S, et al. Heightened inflammation in severe malaria is associated with decreased IL-10 expression levels and neutrophils. Innate Immun. 2015;21(5):546–552. DOI:10.1177/1753425914561277.
   PubMed Web of Science ®Google Scholar
• Tahar R, Albergaria C, Zeghidour N, et al. Plasma levels of eight different mediators and their potential as biomarkers of various clinical malaria conditions in African children. Malar J. 2016;15(1):337. DOI:10.1186/s12936-016-1378-3.
   PubMedGoogle Scholar
• Vera IM, Kessler A, Ting LM, et al. Plasma cell-free DNA predicts pediatric cerebral malaria severity. JCI Insight. 2020;5(12):e136279. https://doi.org/10.1172/jci.insight.136279.
   PubMed Web of Science ®Google Scholar
• Duffy F, Bernabeu M, Babar PH, et al. Meta-analysis of Plasmodium falciparum var signatures contributing to severe malaria in African children and Indian adults. Mbio. 2019;10(2):e00217–19. https://doi.org/10.1128/mBio.00217-19.
   PubMed Web of Science ®Google Scholar
• Imwong M, Woodrow CJ, Hendriksen ICE, et al. Plasma concentration of parasite DNA as a measure of disease severity in falciparum malaria. J Infect Dis. 2015;211(7):1128–1133. DOI:10.1093/infdis/jiu590.
   PubMed Web of Science ®Google Scholar
• Ray S, Patel SK, Venkatesh A, et al. Clinicopathological analysis and multipronged quantitative proteomics reveal oxidative stress and cytoskeletal proteins as possible markers for severe vivax malaria. Sci Rep. 2016;6(1):24557. DOI:http://dx.doi.org/10.1038/srep24557.
   PubMedGoogle Scholar
• Kumar V, Ray S, Aggarwal S, et al. Multiplexed quantitative proteomics provides mechanistic cues for malaria severity and complexity. Commun Biol. 2020;3(1):683. DOI:http://dx.doi.org/10.1038/s42003-020-01384-4.
   PubMed Web of Science ®Google Scholar
• Öner D, Drysdale SB, McPherson C, et al. Biomarkers for disease severity in children infected with respiratory syncytial virus: a systematic literature review. J Infect Dis. 2020;222:S648–S657.
   PubMed Web of Science ®Google Scholar
• Danwang C, Endomba FT, Nkeck JR, et al. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomarker Res. 2020;8(1):37. DOI:10.1186/s40364-020-00217-0.
   PubMed Web of Science ®Google Scholar
• Samprathi M, Jayashree M. Biomarkers in COVID-19: an up-to-date review. Front Pediatr. 2021;8:607647.
   PubMed Web of Science ®Google Scholar
• Achonduh-Atijegbe O, Mbange AE, Atogho-Tiedeu B, et al. Predominance of Plasmodium malariae-falciparum co-infection by molecular speciation in Bangolan, North West Region of Cameroon. J Life Sci. 2013;7:599–606.
   Google Scholar
• Kotepui M, Kotepui KU, De Jesus Milanez G, et al. Plasmodium spp. mixed infection leading to severe malaria: a systematic review and meta-analysis. Sci Rep. 2020;10(1):11068. https://doi.org/10.1038/s41598-020-68082-3.
   PubMed Web of Science ®Google Scholar
• Kojom LP, Singh V. Prevalence of Plasmodium falciparum field isolates with deletions in histidine-rich protein 2 and 3 genes in context with sub-Saharan Africa and India: a systematic review and meta-analysis. Malar J [Internet]. 2020;19(1):46. https://doi.org/10.1186/s12936-019-3090-6.
   PubMedGoogle Scholar
• Singh V, Kojom LP. Deletions in the Plasmodium falciparum histidine-rich protein 2 gene: an emerging threat to the elimination of malaria in India. J Vector Borne Dis. 2019;56(1):85–86.
   PubMed Web of Science ®Google Scholar
• Gendrot M, Fawaz R, Dormoi J, et al. Genetic diversity and deletion of Plasmodium falciparum histidine-rich protein 2 and 3: a threat to diagnosis of P. falciparum malaria. Clin Microbiol Infect. 2019;25(5):580–585. DOI:10.1016/j.cmi.2018.09.009.
   PubMed Web of Science ®Google Scholar
• Cox-Singh J. Zoonotic malaria: Plasmodium knowlesi, an emerging pathogen. Curr Opin Infect Dis. 2012;25(5):530–536.
   PubMed Web of Science ®Google Scholar
• William T, Jelip J, Menon J, et al. Changing epidemiology of malaria in Sabah, Malaysia: increasing incidence of Plasmodium knowlesi. Malar J. 2014;13(1):390. DOI:10.1186/1475-2875-13-390.
   PubMedGoogle Scholar
• Barber BE, Rajahram GS, Grigg MJ, et al. World malaria report: time to acknowledge Plasmodium knowlesi malaria. Malar J. 2017;16(1):135. DOI:10.1186/s12936-017-1787-y.
   PubMedGoogle Scholar
• Chen Y, Chan CK, Kerishnan JP, et al. Identification of circulating biomarkers in sera of Plasmodium knowlesi-infected malaria patients – comparison against Plasmodium vivax infection. BMC Infect Dis. 2015;15(1):49. DOI:10.1186/s12879-015-0786-2.
   PubMedGoogle Scholar
• Ray S, Kumar V, Bhave A, et al. Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity. J Proteomics. 2015;127:103–113.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Georgiadou A, Otto TD, et al. Transcriptomic studies of malaria: a Paradigm for investigation of systemic host-pathogen interactions. Microbiol Mol Biol Rev. 2018;82(2):1–37. DOI:10.1128/MMBR.00071-17.
   Web of Science ®Google Scholar
• Moussa EM, Huang H, Thézénas ML, et al. Proteomic profiling of the plasma of Gambian children with cerebral malaria. Malar J. 2018;17(1):337. https://doi.org/10.1186/s12936-018-2487-y.
   PubMedGoogle Scholar
• Cortez MA, Bueso-Ramos C, Ferdin J, et al. MicroRnas in body fluids—the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8(8):467–477. DOI:10.1038/nrclinonc.2011.76.
   PubMed Web of Science ®Google Scholar
• Chamnanchanunt S, Fucharoen S, Umemura T. Circulating microRnas in malaria infection: Bench to bedside. Malar J. 2017;16(1):334.
   PubMedGoogle Scholar
• Rangel G, Teerawattanapong N, Chamnanchanunt S, et al. Candidate microRnas as biomarkers in malaria infection: a systematic review. Curr Mol Med. 2019;20(1):36–43. DOI:10.2174/1566524019666190820124827.
   PubMed Web of Science ®Google Scholar
• Gupta H, Rubio M, Sitoe A, et al. Plasma MicroRNA profiling of Plasmodium falciparum biomass and association with severity of malaria disease. Emerg Infect Dis. 2021;27(2):430–442. DOI:10.3201/eid2702.191795.
   PubMed Web of Science ®Google Scholar
• Casals-Pascual C, Idro R, Gicheru N, et al. High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc Natl Acad Sci, USA. 2008;105(7):2634–2639. DOI:10.1073/pnas.0709715105.
   PubMed Web of Science ®Google Scholar
• Dembele BP, Chagan-Yasutan H, Niki T, et al. Plasma levels of Galectin-9 reflect disease severity in malaria infection. Malar J. 2016;15(1):403. DOI:10.1186/s12936-016-1471-7.
   PubMedGoogle Scholar
• Kaminski L-C, Riehn M, Abel A, et al. Cytotoxic T cell-derived granzyme B is increased in severe Plasmodium falciparum malaria. Front Immunol. 2019;10:2917.
   PubMed Web of Science ®Google Scholar
• Pankoui Mfonkeu JB, Gouado I, Fotso Kuaté H, et al. Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS One. 2010;5(10):e13415. DOI:10.1371/journal.pone.0013415.
   PubMed Web of Science ®Google Scholar
• Thonsranoi K, Glaharn S, Punsawad C, et al. Increased synapsin I expression in cerebral malaria. Int J Clin Exp Pathol. 2015;8(11):13996–14004.
   PubMed Web of Science ®Google Scholar
• Rommelaere S, Millet V, Rihet P, et al. Serum pantetheinase/vanin levels regulate erythrocyte homeostasis and severity of malaria. Am J Pathol. 2015;185(11):3039–3052. DOI:http://dx.doi.org/10.1016/j.ajpath.2015.07.011.
   PubMed Web of Science ®Google Scholar
• Cheng IS, Sealy BC, Tiberti N, et al. Extracellular vesicles, from pathogenesis to biomarkers: the case for cerebral malaria. Vessel Plus. 2020;4:17.
   Google Scholar
• Tolosano E, Altruda F. Hemopexin: Structure, function, and regulation. DNA Cell Biol. 2002;21(4):297–306.
   PubMed Web of Science ®Google Scholar
• Elphinstone RE, Conroy AL, Hawkes M, et al. Alterations in systemic extracellular heme and hemopexin are associated with adverse clinical outcomes in Ugandan children with severe malaria. J Infect Dis. 2016;214(8):1268–1275. DOI:10.1093/infdis/jiw357.
   PubMed Web of Science ®Google Scholar
• Orzheshkovskyi V, Trishchynska M. Ceruloplasmin: Its role in the physiological and pathological processes. Neurophysiol. 2019;51(2):141–149.
   Google Scholar
• Steinhoff JS, Lass A, Schupp M. Biological functions of RBP4 and its relevance for human diseases. Front Physiol. 2021;12:659977.
   PubMed Web of Science ®Google Scholar
• Aisina RB, Mukhametova LI. Structure and function of plasminogen/plasmin system. Russ J Bioorg Chem. 2014;40(6):590–605.
   Web of Science ®Google Scholar
• Vlad C, Burlacu A, Florea L, et al. A comprehensive review on apolipoproteins as nontraditional cardiovascular risk factors in end-stage renal disease: current evidence and perspectives. Int Urol Nephrol. 2019;51(7):1173–1189. https://doi.org/10.1007/s11255-019-02170-w.
   PubMed Web of Science ®Google Scholar
• Dietmann A, Helbok R, Lackner P, et al. Endoglin in African children with Plasmodium falciparum malaria: a novel player in severe malaria pathogenesis? J Infect Dis. 2009;200(12):1842–1848. DOI:10.1086/648476.
   PubMed Web of Science ®Google Scholar
• Nduati E, Gwela A, Karanja H, et al. The plasma concentration of the B cell activating factor is increased in children with acute malaria. J Infect Dis. 2011;204(6):962–970. DOI:10.1093/infdis/jir438.
   PubMed Web of Science ®Google Scholar
• Wenisch C, Spitzauer S, Florris-Linau K, et al. Complement activation in severe Plasmodium falciparum malaria. Clin Immunol Immunopathol. 1997;85(2):166–171. DOI:10.1006/clin.1997.4417.
   PubMedGoogle Scholar
• Urban BC, Cordery D, Shafi MJ, et al. The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria. Infect Immun. 2006;74(12):6700–6706. DOI:10.1128/IAI.00861-06.
   PubMed Web of Science ®Google Scholar
• Harawa V, Njie M, Keller T, et al. Malawian children with uncomplicated and cerebral malaria have decreased activated Vγ9Vδ2 γδ T cells which increase in convalescence. PLoS One. 2019;14(10):e0223410. DOI:10.1371/journal.pone.0223410.
   PubMed Web of Science ®Google Scholar
• Barber BE, William T, Grigg MJ, et al. Asymmetric dimethylarginine in adult falciparum malaria: relationships with disease severity, antimalarial treatment, hemolysis, and inflammation. Open Forum Infect Dis. 2016;3(1):ofw027. DOI:10.1093/ofid/ofw027.
   PubMed Web of Science ®Google Scholar
• Barber BE, Grigg MJ, Piera KA, et al. Endothelial glycocalyx degradation and disease severity in Plasmodium vivax and Plasmodium knowlesi malaria. Sci Rep. 2021;11(1):9741. https://doi.org/10.1038/s41598-021-88962-6.
   PubMed Web of Science ®Google Scholar
• Melo GC, Monteiro WM, Siqueira AM, et al. Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon. PLoS One. 2014;9:e105922.
   PubMedGoogle Scholar
• Buyon LE, Elsworth B, Duraisingh MT. The molecular basis of antimalarial drug resistance in Plasmodium vivax. Int J Parasitol Drugs Drug Resist. 2021;16:23–37.
   PubMed Web of Science ®Google Scholar